Two-dose epoetin alfa reduces blood transfusions compared with autologous donation

Clinical Orthopaedics and Related Research

Volumn 423, Issue , 2004, Pages 240-244

  Hardwick, Mary E ^a   Morris, Beverly M ^a   Colwell Jr , Clifford W ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; ELECTIVE SURGERY; FEMALE; HEALTH CARE COST; HIP ARTHROPLASTY; HUMAN; INFORMED CONSENT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 2942735287     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000130206.58617.9e     Document Type: Article

References (13)

1. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341:1227-1232, 1993.
2. Carson JL: Morbidity risk assessment in the surgically anemic patient. Am J Surg 170(6A Suppl):32S-36S, 1995.
3. de Andrade JR, Frei D, Guilfoyle M: Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopaedic surgery. Orthopedics 22(1 Suppl):s113-s118, 1999.
4. Desmond MJ, Thomas MJ, Gillon J, Fox MA: Consensus conference on autologous transfusion: Perioperative red cell salvage. Transfusion 36:644-651, 1996,
5. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation: The American Erythropoietin Study Group. J Bone Joint Surg 78A:62-72, 1996.
6. Goldberg MA: A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25:544-552, 1996.
7. Gombotz H, Gries M, Sipurzynski S, Fruhwald S, Rehak P: Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. Acta Anaesthesiol Scand 44:737-742, 2000.
8. Grosvenor D, Goyal V, Goodman S: Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg 82A:951-954, 2000.
9. National Institutes of Health: Consensus conference: Perioperative red blood cell transfusion. JAMA 260:2700-2703, 1988.
10. Nelson CL, Bowen WS: Total hip arthroplasty in Jehovah's Witnesses without blood transfusion. J Bone Joint Surg 68A:350-353, 1986.
11. Oishi CS, D'Lima DD, Morris BA, et al: Hemodilution with other reinfusion techniques in total hip arthroplasty. Clin Orthop 339:132-139, 1997.
12. Spence RK: Anemia in the patient undergoing surgery and the transfusion decision: A review. Clin Orthop 357:19-29, 1998.
13. Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC: An open-label, randomized study to compare the efficacy of perioperative EPO with preoperative autologous donation in total joint arthroplasty. Orthopedics 22(1 Suppl):s105-s112, 1999.